These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3508523)

  • 21. TCP-FA4: a derivative of tranylcypromine showing improved blood-brain permeability.
    Desino KE; Pignatello R; Guccione S; Basile L; Ansar S; Michaelis ML; Ramsay RR; Audus KL
    Biochem Pharmacol; 2009 Dec; 78(11):1412-7. PubMed ID: 19679106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of 3-methoxytyramine in rat brain by HPLC with electrochemical detection and its correlation with dopamine function after administration of a monoamine oxidase inhibitor and L-3,4-dihydroxyphenylalanine.
    Davies CL; Heal DJ
    J Neurochem; 1986 Dec; 47(6):1919-23. PubMed ID: 3772383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ; Coulson CJ; Maxwell DR; Riddell D
    Br J Pharmacol; 1972 Jul; 45(3):490-503. PubMed ID: 5072232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo, noradrenaline is a substrate for rat brain monoamine oxidase A and B.
    Youdim MB
    Br J Pharmacol; 1983 Jun; 79(2):477-80. PubMed ID: 6652339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 26. The effects of tranylcypromine isomers on norepinephrine-H3 metabolism in rat brain.
    Reigle TG; Orsulak PJ; Avni J; Platz PA; Schildkraut JJ
    Psychopharmacology (Berl); 1980; 69(2):193-9. PubMed ID: 6779313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
    Wiest SA; Steinberg MI
    Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbamate prodrugs of phenylethylamines: a neurochemical investigation.
    Baker GB; Coutts RT; Nazarali AJ; Danielson TJ; Rubens M
    Proc West Pharmacol Soc; 1984; 27():523-5. PubMed ID: 6494193
    [No Abstract]   [Full Text] [Related]  

  • 30. Tranylcypromine enhancement of nicotine self-administration.
    Villégier AS; Lotfipour S; McQuown SC; Belluzzi JD; Leslie FM
    Neuropharmacology; 2007 May; 52(6):1415-25. PubMed ID: 17412372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tranylcypromine in mind (Part II): Review of clinical pharmacology and meta-analysis of controlled studies in depression.
    Ricken R; Ulrich S; Schlattmann P; Adli M
    Eur Neuropsychopharmacol; 2017 Aug; 27(8):714-731. PubMed ID: 28579071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of monoamine oxidase inhibitors on the concentrations of free and conjugated dopamine in rat small intestine and liver following exogenous dopamine administration].
    Morooka H
    Masui; 1989 Aug; 38(8):1061-7. PubMed ID: 2810701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat.
    Assareh N; ElBatsh MM; Marsden CA; Kendall DA
    Pharmacol Biochem Behav; 2012 Jan; 100(3):506-12. PubMed ID: 22037406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical changes in rat brain amines after short- and long-term inhibition of monoamine oxidase by a low dose of tranylcypromine.
    Hampson DR; Baker GB; Coutts RT
    Biol Psychiatry; 1988 Feb; 23(3):227-36. PubMed ID: 3337860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of brain amines in the fetal hyperpyrexia caused by tranylcypromine in LiCl-pretreated rats.
    Shimomura K; Hashimoto M; Mori J; Honda F
    Jpn J Pharmacol; 1979 Apr; 29(2):161-70. PubMed ID: 161335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparisons of the actions of high and low doses of the MAO inhibitor tranylcypromine on 5-HT2 binding sites in rat cortex.
    Goodnough DB; Baker GB
    J Neural Transm Suppl; 1994; 41():127-34. PubMed ID: 7931218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure to detect amphetamine or 1-amino-3-phenylpropane in humans or rats receiving the MAO inhibitor tranylcypromine.
    Sherry RL; Rauw G; McKenna KF; Paetsch PR; Coutts RT; Baker GB
    J Affect Disord; 2000 Dec; 61(1-2):23-9. PubMed ID: 11099737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redox derivatives of tranylcypromine: syntheses, properties, and monoamine oxidase inhibitor activity of some chemical delivery systems.
    Prókai-Tátrai K; Pop E; Anderson W; Lin JL; Brewster ME; Bodor N
    J Pharm Sci; 1991 Mar; 80(3):255-61. PubMed ID: 2051343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium alters the stereoselectivity of monoamine oxidase in rat brain.
    Smith DF
    J Neural Transm; 1989; 76(3):205-10. PubMed ID: 2732725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.